Zdrowie i gospodarka · 30/03/1994
Opportunity For Licensing: Calanolide Antiviral Compounds as Antiviral Agents Useful in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)
The National Institutes of Health (NIH) is seeking a licensee to develop calanolide A or related anti-viral compounds for treating human immunodeficiency virus (HIV) infection, with the goal of treating Acquired Immunodeficiency Syndrome (AIDS).